<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Havering South PCN</h1>
        This is some intro text.

        <h2>Prescribing where Havering South PCN is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm">
            <thead>


                <tr>
                    <th>BNF Chemical</th>
                    <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
                    <th>BNF Subparagraph</th>
                    <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
                    <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
                    <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
                    <th><abbr title="Standard Deviation">std</abbr></th>
                    <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
                    <th>Plots</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U00367&amp;numIds=0402020AC&amp;denomIds=4.2.2&amp;selectedTab=summary">Olanzapine Embonate</a></th>
                    <td>7</td>
                    <td>Antipsychotic Depot Injections</td>
                    <td>56</td>
                    <td>0.12</td>
                    <td>0.00</td>
                    <td>0.01</td>
                    <td>22.40</td>
                    <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAV4AAABkCAYAAADOvVhlAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAPYQAAD2EBqD+naQAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAGb0lEQVR4nO3dX8hkdR3H8fevXBfattUIFXXzoJUgK+3uXSBYNxJNQRcJXeRFppC03UjpMcWIRMc/gYG0ZkQERXTRH6gTJEgR3W+hmELokIp2o+6q1bquPy/OWXp6dO3MznO+v3Oc9wuGZ3Zmzvw+zDPnw9nf+fOknDOSpDjvKh1AktaNxStJwSxeSQpm8UpSMItXkoJZvJIUzOKVpGAWryQFs3glKZjFK0nBLF5JCmbxSlIwi1eSglm8khTM4pU0fSntJ6VMSvtLR+nD4pWkYBavJAUbtHiruvn6kO8vSVM09Bbv7VXd3DzwGJI0KUMX75XAN6u6OTDwOJI0GYMW72I++zVwL20BS5KI2bl2CLi0qpsUMJYkjV5E8T4MnAmcGzCWJI1eRPE+DhwDLg0YS5JGb/DiXcxnx4DHgD1DjyVJUxB1AsXDuMUrSYDFK0nhIov3kqpuTgsaT5JGK7J4twMfChpPkkYrqnifAo7gdIMkxRTvYj7LwCNYvJIUellId7BJEvHF67G8ktZedPFeVNXNjsAxJWl0oos3AZcEjilJoxNWvIv57AXgGZznlbTmov/mmjvYJK09i1eSglm8khSsRPGeVdXN2cHjStJoRBfvo7QXRd8XPK4kjUZo8S7ms1dpTx22eCWtregtXoC/AHsLjCtJo1CieA/hFq+kNVaqeD9c1c3OAmNLUnElivevQAY+WmBsSSouvHgX89lLwN9xukHSmiqxxQvuYJO0xkoVrzvYJK2tksW7p6qb0wuNL0nFlCzebXhtXklrqEjxLuazfwLP4nSDpDVUaosX3MEmaU2VLF53sElaS6WLd29VNyUzSFK40sW7E7iwYAZJCleyeJ8EjgD7C2aQpHDFincxn70OPARcWSqDJJVQen71AeCzVd2cUziHJIUpXbwPAk8DVxfOIUlhihZvN93wAHCtRzdIWhdjKLsfAecDV5QOIkkRihfvYj57DvgV8OXSWSQpQvHi7Xwf+HRVN+eVDiJJQxtL8f4BeAK4pnQQSRraKIq328n2XeDmqm7qqm7eXTqTJA1lFMXb+R7tYWU18Keqbi4qnEeSBpFyzqUz/I+qbnbTHulwGfAosOhuLwDHgdc2/TwOvL7isKt+CCWXn3L20suf6rJ9lvt/r1n1+b6vWQtfONRUtz148PZbrrjuGz/ZN1tEjLmYz352qssOVrwppe3ATcAdOeejgwyyxaaYGaaZ28xxpph7ipmXMWTxvg84DOzKOR8ZZJAtNsXMMM3cZo4zxdxTzLyMMc3xStJasHglKZjFK0nBhizeo8C3up9TMcXMMM3cZo4zxdxTzNzb6A4nk6R3OqcaJCmYxStJwSxeSQp22qpvkFLaQXudhVeBP+acf9o9vof2zBNozz55JKU0B94D/CvnXK869qnqmxk4BtwIJOCxnPOdBeLSZev9OXeP3w+8nHP+Wom8Jyz5/bga2AcczjnfUiQwS30//gb8GPg3cDrwxZzzqqevn5K3yfwp4ADwu5zzfd1jo1gPuyy9cqeULmYk6+KWyDmvdAOuAj7T3f/5hsd/AJwB7KK93u4Hge90z90N7F517KEzb1rml6XyLpsZ+BzwJeCekpmX/H6cBfwemANfmUjmM4CD3XMHgfePLXP3748DB7r7o1kPl8m96fGi6+JW3LZiquF84Knu/vENj+/KOb+Ycz4M7ATO2/C6f3TLldI3MwAppc/T/mHOknplTimdTbvV+FB0wJPo+1lfCDyf2y2wC1JKJa9O1zfzEWB7SqkBtuWcnw/OudHJMm82pvUQ+ucGRrMurmwrivdp/vvL2/h+h1NKu7pzrl8Cntnwut3dcqX0zXziF31Bzvn+4Iyb9c18Oe3W463AJ1JKH4mN+SbLfD9OFNeLwHvjIr5J38z7gUXOeQY8mVLaG5xzo5Nl3mxM6yH0zz2mdXFlKx/H283R3Af8B/gz8Mmc81XdfNgN3cvuyu0c3h3AduBozvmmt37H4fXNDGwDfgP8lnY+7PoSeWG5z7l7fUX737QxzPH2/X58G9hBu/X41TKJl/p+PAH8kPaSpR+gneN9pUDkt8v8Mdp56TOBe3POvxjLegj9c9N+1qNYF7eCJ1BIUjAPJ5OkYBavJAWzeCUpmMUrScEsXkkKZvFKUjCLV5KCWbySFMzilaRgFq8kBbN4JSmYxStJwSxeSQpm8UpSMItXkoK9AR1wqpJzU4ePAAAAAElFTkSuQmCC"></td>
                </tr>
                <tr>
                    <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U00367&amp;numIds=0504010AA&amp;denomIds=5.4.1&amp;selectedTab=summary">Artemether with Lumefantrine</a></th>
                    <td>1</td>
                    <td>Antimalarials</td>
                    <td>2594</td>
                    <td>0.00</td>
                    <td>0.00</td>
                    <td>0.00</td>
                    <td>8.41</td>
                    <td><img class="zoom" src="data:image/png;base64,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"></td>
                </tr>
                <tr>
                    <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U00367&amp;numIds=0905021L0&amp;denomIds=9.5.2&amp;selectedTab=summary">Sodium Dihydrogen Phosphate Dihydrate</a></th>
                    <td>5</td>
                    <td>Phosphate Supplements</td>
                    <td>11</td>
                    <td>0.45</td>
                    <td>0.01</td>
                    <td>0.09</td>
                    <td>4.87</td>
                    <td><img class="zoom" src="data:image/png;base64,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"></td>
                </tr>
                <tr>
                    <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U00367&amp;numIds=1106000AM&amp;denomIds=11.6&amp;selectedTab=summary">Tafluprost &amp; Timolol</a></th>
                    <td>258</td>
                    <td>Treatment Of Glaucoma</td>
                    <td>10811</td>
                    <td>0.02</td>
                    <td>0.00</td>
                    <td>0.00</td>
                    <td>4.77</td>
                    <td><img class="zoom" src="data:image/png;base64,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"></td>
                </tr>
                <tr>
                    <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U00367&amp;numIds=0604030L0&amp;denomIds=6.4.3&amp;selectedTab=summary">Nandrolone Decanoate</a></th>
                    <td>2</td>
                    <td>Anabolic Steroids</td>
                    <td>2</td>
                    <td>1.00</td>
                    <td>0.05</td>
                    <td>0.22</td>
                    <td>4.41</td>
                    <td><img class="zoom" src="data:image/png;base64,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"></td>
                </tr>
            </tbody>
        </table>

        <h2>Prescribing where Havering South PCN is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm">
            <thead>


                <tr>
                    <th>BNF Chemical</th>
                    <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
                    <th>BNF Subparagraph</th>
                    <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
                    <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
                    <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
                    <th><abbr title="Standard Deviation">std</abbr></th>
                    <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
                    <th>Plots</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U00367&amp;numIds=090502100&amp;denomIds=9.5.2&amp;selectedTab=summary">Other Phosphate Supplement Preps</a></th>
                    <td>6</td>
                    <td>Phosphate Supplements</td>
                    <td>11</td>
                    <td>0.55</td>
                    <td>0.99</td>
                    <td>0.10</td>
                    <td>-4.23</td>
                    <td><img class="zoom" src="data:image/png;base64,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"></td>
                </tr>
                <tr>
                    <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U00367&amp;numIds=0310000N0&amp;denomIds=3.10&amp;selectedTab=summary">Pseudoephedrine Hydrochloride</a></th>
                    <td>3</td>
                    <td>Systemic Nasal Decongestants</td>
                    <td>6</td>
                    <td>0.50</td>
                    <td>0.96</td>
                    <td>0.15</td>
                    <td>-3.02</td>
                    <td><img class="zoom" src="data:image/png;base64,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"></td>
                </tr>
                <tr>
                    <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U00367&amp;numIds=1311060Q0&amp;denomIds=13.11.6&amp;selectedTab=summary">Potassium Permanganate</a></th>
                    <td>3</td>
                    <td>Oxidisers &amp; Dyes</td>
                    <td>9</td>
                    <td>0.33</td>
                    <td>0.93</td>
                    <td>0.20</td>
                    <td>-2.97</td>
                    <td><img class="zoom" src="data:image/png;base64,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"></td>
                </tr>
                <tr>
                    <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U00367&amp;numIds=0604030Q0&amp;denomIds=6.4.3&amp;selectedTab=summary">Prasterone</a></th>
                    <td>0</td>
                    <td>Anabolic Steroids</td>
                    <td>2</td>
                    <td>0.00</td>
                    <td>0.89</td>
                    <td>0.32</td>
                    <td>-2.81</td>
                    <td><img class="zoom" src="data:image/png;base64,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"></td>
                </tr>
                <tr>
                    <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U00367&amp;numIds=0208020V0&amp;denomIds=2.8.2&amp;selectedTab=summary">Warfarin Sodium</a></th>
                    <td>1540</td>
                    <td>Oral Anticoagulants</td>
                    <td>14246</td>
                    <td>0.11</td>
                    <td>0.35</td>
                    <td>0.11</td>
                    <td>-2.32</td>
                    <td><img class="zoom" src="data:image/png;base64,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"></td>
                </tr>
            </tbody>
        </table>
</body>

</html>